Literature DB >> 11258621

Complex host cell responses to antisense suppression of ACHE gene expression.

N Galyam1, D Grisaru, M Grifman, N Melamed-Book, F Eckstein, S Seidman, A Eldor, H Soreq.   

Abstract

3'-End-capped, 20-mer antisense oligodeoxynucleotides (AS-ODN) protected with 2'-O-methyl (Me) or phosphorothioate (PS) substitutions were targeted to acetylcholinesterase (AChE) mRNA and studied in PC12 cells. Me-modified AS-ODN suppressed AChE activity up to 50% at concentrations of 0.02-100 nM. PS-ODN was effective at 1-100 nM. Both AS-ODN displayed progressively decreased efficacy above 10 nM. In situ hybridization and confocal microscopy demonstrated dose-dependent decreases, then increases, in AChE mRNA. Moreover, labeling at nuclear foci suggested facilitated transcription or stabilization of AChE mRNA or both under AS-ODN. Intracellular concentrations of biotinylated oligonucleotide equaled those of target mRNA at extracellular concentrations of 0.02 nM yet increased only 6-fold at 1 microM ODN. Above 50 nM, sequence-independent swelling of cellular, but not nuclear, volume was observed. Our findings demonstrate suppressed AChE expression using extremely low concentrations of AS-ODN and attribute reduced efficacy at higher concentrations to complex host cell feedback responses.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11258621     DOI: 10.1089/108729001750072128

Source DB:  PubMed          Journal:  Antisense Nucleic Acid Drug Dev        ISSN: 1087-2906


  2 in total

1.  Excessive expression of acetylcholinesterase impairs glutamatergic synaptogenesis in hippocampal neurons.

Authors:  Haiheng Dong; Yun-Yan Xiang; Noa Farchi; William Ju; Yaojiong Wu; Liwen Chen; Yutian Wang; Binyamin Hochner; Burton Yang; Hermona Soreq; Wei-Yang Lu
Journal:  J Neurosci       Date:  2004-10-13       Impact factor: 6.167

2.  CREB regulates AChE-R-induced proliferation of human glioblastoma cells.

Authors:  Chava Perry; Ella H Sklan; Hermona Soreq
Journal:  Neoplasia       Date:  2004 May-Jun       Impact factor: 5.715

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.